PubMed Health⌕ Search

Biomedical subjects

M T Muñoz Yagüe

Publications and source records attributed to M T Muñoz Yagüe.

5 recordsLinked to original sources

Non-alcoholic fatty liver disease. From insulin resistance to mitochondrial dysfunction.

Non-alcoholic fatty liver disease represents a set of liver lesions similar to those induced by alcohol that develop in individuals with no alcohol abuse. When lesions consist of fatty and hydropic degeneration, inflammation, and eventually fibrosis, the condition is designated non-alcoholic steatohepatitis (NASH). The pathogenesis of these lesions is not clearly understood, but they are associated with insulin resistance in most cases. As a result, abdominal fat tissue lipolysis and excessive fatty acid uptake by the liver occur. This, together with a disturbance of triglyceride export as VLDL, results in fatty liver development. Both the inflammatory and hepatocellular degenerative components of NASH are attributed to oxidative stress. Mitochondrial respiratory chain loss of activity plays a critical role in the genesis of latter stress. This may be initiated by an increase in the hepatic TNFalpha, iNOS induction, peroxynitrite formation, tyrosine nitration and inactivation of enzymes making up this chain. Consequences of oxidative stress include: lipid peroxidation in cell membranes, stellate cell activation in the liver, liver fibrosis, chronic inflammation, and apoptosis.

Clinical Trials as Topic↗

[Assessment of hepatic fibrosis].

Diagnosis of liver diseases is mainly based on histological criteria, therefore, liver biopsy uses to provide a final diagnosis in most of the cases. However, this procedure is associated with a risk of morbidity and morality, hence, a non-invasive method of assessing liver features would be helpful. Many serological tests have been used to assess degree of liver fibrosis, however, none of them has demonstrated to be specific enough for fibrosis. This is the case of the aminoterminal procollagen type III propeptide, the monovalent Fab fragment of antibodies against procollagen III or measurement of laminin P1 or fragments 7S and NC1 of type IV collagen. High serum levels of these markers are usually found in chronic active liver disease, however, these levels seems to be more closely related with inflammatory activity and fibrogenesis than with the degree of fibrosis. More recently, attention has been focused on the physical characterization of liver tissue by using ultrasound, nuclear magnetic resonance or spectroscopy. Although, none of these new methods has proved to be useful in assessing liver fibrosis sofar, we should hope that future improvements may allow better non-invasive quantification of liver fibrosis.

Humans↗